Concepedia

Robert E. Lee Trout

RE

11

Publications

1.1K

Citations

11

H-Index

1997

Active since

Affiliations

GlaxoSmithKline (United States)(Current)

VenatoRx Pharmaceuticals (United States)

University of North Texas Health Science Center

University of North Texas System

University of North Texas

Robert E. Lee Trout is an author at GlaxoSmithKline (United States) specializing in pharmacology, drug discovery, and natural sciences.

ORCID

Top concepts

Publications per year

1997–2021

11

Publications

11

Systemic Activation of the Transient Receptor Potential Vanilloid Subtype 4 Channel Causes Endothelial Failure and Circulatory Collapse: Part 2

Robert N. Willette, Weike Bao, Sandhya S. Nerurkar et al. · Journal of Pharmacology and Experimental Therapeutics · 2008 · 291 citations

Discovery of Taniborbactam (VNRX-5133): A Broad-Spectrum Serine- and Metallo-β-lactamase Inhibitor for Carbapenem-Resistant Bacterial Infections

Bin Liu, Robert E. Lee Trout, Guo‐Hua Chu et al. · Journal of Medicinal Chemistry · 2019 · 281 citations · Full text

VNRX-5133 (Taniborbactam), a Broad-Spectrum Inhibitor of Serine- and Metallo-β-Lactamases, Restores Activity of Cefepime in <i>Enterobacterales</i> and Pseudomonas aeruginosa

Jodie C. Hamrick, Jean‐Denis Docquier, Tsuyoshi Uehara et al. · Antimicrobial Agents and Chemotherapy · 2019 · 204 citations · Full text

Spongistatin synthetic studies. 2. Assembly of the C(18–28) spiroketal

Amos B. Smith, Linghang Zhuang, Christopher S. Brook et al. · Tetrahedron Letters · 1997 · 52 citations · Full text

Cyclic Ketone Inhibitors of the Cysteine Protease Cathepsin K

Robert W. Marquis, Yu Ru, Jin Zeng et al. · Journal of Medicinal Chemistry · 2001 · 52 citations · Full text

, , +13

Rows per page

1–5 of 11